Filter
157
Text search:
genotypic
testing
Featured
Recommendations
25
New Publications
48
Language
Document type
No document type
93
Guidelines
31
Studies & Reports
23
Manuals
6
Strategic & Response Plan
4
Countries / Regions
India
8
Western and Central Europe
6
Ethiopia
5
Africa
4
Eastern Europe
4
Myanmar / Burma
3
Zambia
2
Kenya
2
Malawi
2
Mozambique
2
Latin America and the Carribbean
2
Asia
2
Russia
2
Estonia
2
Sierra Leone
1
Nigeria
1
Senegal
1
USA
1
Uganda
1
Philippines
1
Tanzania
1
Thailand
1
Bangladesh
1
Benin
1
North Macedonia
1
Colombia
1
Botswana
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Georgia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
39
Clinical Guidelines
30
Pharmacy & Technologies
10
Public Health
8
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
TB
51
HIV
27
AMR
14
Rapid Response
5
COVID-19
5
NTDs
5
Mental Health
3
Pharmacy
3
Polio
2
Refugee
2
Ebola
1
Natural Hazards
1
Caregiver
1
NCDs
1
Meeting Report
27–30 June 2017 Manila, Philippines
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A
...
Policy framework.
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable
...
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Copenhagen, Denmark, 24–25 August 2017
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8
...
Guidelines
HIV drug resistance
July 2017
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill
...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical
...
A survey of prevention, testing and treatment policies and practices
